The Main Street Pharmacy Access Act would let Medicare pay pharmacists for care they can already legally provide, if pharmacies have the time.
|Articles|December 8, 2021
Daily OTC Pearl: Ayr Saline Nasal Gel
Author(s)Saro Arakelians, PharmD
Ayr helps add moisture inside the nose to dissolve and soften thick or crusty mucus.
Advertisement
OTC/Lifestyle Pearl of the Day: Ayr Saline Nasal Gel
Indication: Ayr is used to treat dryness inside the nose (nasal passages).
Insight:
- Ayr helps add moisture inside the nose to dissolve and soften thick or crusty
mucus . - In babies and young children with stuffy noses who cannot blow their noses, using this product helps to make the mucus easier to remove with a nasal bulb syringe. This helps relieve stuffiness and makes breathing easier.
- This product contains a purified gentle salt solution, also called saline or sodium
chloride solution. It does not contain anymedication . - Directions: Spray Ayr into each nostril as needed or as directed by a physician. This product may also be given into the nose as drops or a stream.
- Adverse effects usually do not occur with use of this product. However, if the inside of the nose is very dry and irritated, stinging may occur. If this effect persists or worsens, a physician or
pharmacist should be contacted promptly. - Caution: Do not share this product with others.
Sources:
Advertisement
Related to this article
Each October, the pharmacy profession pauses to recognize technicians' decades-long evolution, from on-the-job trainees to nationally certified health care professionals.
Experts on Lp(a) testing, statin myths, cognitive safety, and the 2025-2030 Dietary Guidelines share counseling points from the National Lipid Association's Fall Clinical Lipid Update meeting.
At-home chemotherapy for HR+ breast cancer works best when pharmacists guide oral regimens, boosting adherence, safety, and affordable access.
Managing medication safety in specialized populations requires a shift from standardized dosing to precise, patient-specific customization.
Emergency and ICU pharmacists would be most likely to see pneumonic plague. An expert reviews first-line agents, alternatives, and postexposure prophylaxis.
A former residency program director unpacks why this debate keeps resurfacing, and why some reasons people give for skipping residency may not hold up the way they think they do.
Eric Lawitz, MD, explains how pharmacists can discuss liver risk with patients with obesity and why a FIB-4 score from routine blood work is a good first step.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Preparing Pharmacists for Psychedelic Medicine
2
National Pharmacy Technician Day: Celebrating the Backbone of Pharmacy
3
Cemdisiran’s Potential to Reduce Hospitalizations in Myasthenia Gravis
4
Supporting Patients Prescribed Opioids in the Era of “Fentanyl Free America”
5